Experimental Therapies for Ebola Virus Disease: What Have We Learned?

被引：22

|

作者：

Hayden, Frederick G. ^{[1
]}

Friede, Martin ^{[2
]}

Bausch, Daniel G. ^{[2
]}

机构：

[1] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA

[2] World Hlth Org, Geneva, Switzerland

来源：

JOURNAL OF INFECTIOUS DISEASES | 2017年 / 215卷 / 02期

基金：

英国惠康基金;

关键词：

Ebola; antivirals; immunotherapeutics; clinical research; HEMORRHAGIC-FEVER; NONHUMAN-PRIMATES; PERSISTENCE; PATIENT; FLUID;

D O I：

10.1093/infdis/jiw496

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

收藏

页码：167 / 170

页数：4

相关论文

共 50 条

[21] What have we learned?
Ayres, RU
TECHNOLOGICAL FORECASTING AND SOCIAL CHANGE, 1999, 62 (1-2) : 9 - 12
[22] What we have learned
Zeoli, L
JOURNAL OF FORESTRY, 1997, 95 (06) : 35 - 36
[23] What Have We Learned?
Nason, John W.
JOURNAL OF HIGHER EDUCATION, 1944, 15 (06): : 287 - 298
[24] WHAT HAVE WE LEARNED
FRANKEL, FH
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1986, 462 : 411 - 415
[25] WHAT HAVE WE LEARNED
KLEINE, D
JOURNAL OF SOIL AND WATER CONSERVATION, 1995, 50 (04) : 330 - 330
[26] What have we learned?
Winterbottom, Mark
JOURNAL OF BIOLOGICAL EDUCATION, 2021, 55 (02) : 107 - 108
[27] WHAT HAVE WE LEARNED
RAVDIN, IS
MILITARY MEDICINE, 1963, 128 (01) : 56 - &
[28] Enterprise Modeling - What We Have Learned, and What We Have Not
Jorgensen, Havard D.
PRACTICE OF ENTERPRISE MODELING, PROCEEDINGS, 2009, 39 : 3 - 7
[29] Personalizing antiplatelet therapies: What have we learned from recent trials?
Landry, Sebastien
Tanguay, Jean-Francois
Lordkipanidze, Marie
PLATELETS, 2018, 29 (02) : 131 - 139
[30] Ebola in Pregnancy: Have We Learned Any Lessons?
Money, Deborah
JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2015, 37 (02) : 105 - 107

← 1 2 3 4 5 →